The Ensign Group, Inc. · ENSG · FY2026 Q2 · Calendar Q3 2026
Ensign raises guidance as occupancy, quality and acquisitions support growth
Ensign's Q2 analysis supports a constructive operating thesis: demand, care quality and disciplined acquisitions are reinforcing growth, while execution and reimbursement remain the key tests.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about ENSG FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management raised 2026 earnings and revenue guidance and continued its acquisition-led expansion. The call also highlighted successful facility turnarounds, strong operating quality and further Standard Bearer portfolio growth.
Guidance delta
Raised 2026 earnings and revenue guidance.
Key takeaways
- Occupancy and skilled mix remained central supports for performance.
- The ONE CLINICAL model was linked to strong quality outcomes and referrals.
- Acquisitions and Standard Bearer expansion broadened the growth plan.
Management priorities
- Continue acquisitions in existing and new markets.
- Build the leadership pipeline to support operating growth.
- Expand Standard Bearer assets and managed-care and VA relationships.
Follow ENSG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeCompany context
Snapshot as of publicationThe Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions.…
Historical context
All ENSG earningsHealthcare peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| GEHC GE HealthCare Technologies Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +6.6% | GE HealthCare raises 2026 outlook as margins expand |
| LH Labcorp Holdings Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +8.8% | Labcorp raises 2026 outlook as Q3 growth broadens |
| BIIB Biogen Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -3.4% | Biogen Q3: Growth portfolio expands as guidance rises |
| UHS Universal Health Services, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | -2.9% | UHS reaffirms guidance as new-hospital ramps weigh on Q3 |
| GSK GSK plc | FY2026 Q3 · Calendar Q4 2026 | — | -4.3% | GSK reaffirms 2026 guidance as specialty medicines drive Q3 growth |
| BSX Boston Scientific Corporation | FY2026 Q3 · Calendar Q4 2026 | — | -3.5% | BSX Holds 2026 Guide Despite Cyber Hit and EP Pressure |
Latest beats and misses
Who reports nextBeat on EPS
- EVRFY2026 Q3 · October 28, 2026+69.8% EPS+12.5% move
- EXEFY2026 Q3 · October 27, 2026+13.2% EPS-3.2% move
- CRFY2026 Q3 · October 27, 2026+12.6% EPS+2.9% move
- PPGFY2026 Q3 · October 27, 2026+6.1% EPS+4.4% move
- UMBFFY2026 Q3 · October 27, 2026+10.6% EPS-1.1% move
- UHSFY2026 Q3 · October 27, 2026+0.6% EPS-2.9% move
Get the ENSG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-13T20:14:28.509157+00:00
- FN2 earnings calendar · 2026-09-01T01:23:15.986970+00:00
- Polygon adjusted daily market bars · 2026-10-29T02:00:43.045798+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-29T02:00:43.042999+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-29. For educational purposes only; not investment advice.